-transparent.png){kind=logo}
The purpose of these investigations was to determine if phencyclidine (PCP) and/or two of its major monohydroxy metabolites [1-(1-phenylcyclohexyl)4-hydroxy piperidine (4-OH-pip PCP) and 1-(1-phenyl-4-hydroxycyclohexyl) piperidine (4-OH-cyclo PCP)] influence 3H quinuclidinyl benzilate (QNB) binding in rat brain after in vivo administration. PCP and 4-OH-pip PCP but not 4-OH-cyclo PCP enhanced QNB binding. The effect was blocked by atropine. Since the dose of 4-OH-pip PCP necessary to alter QNB binding in rat brain is substantially higher than that required for PCP, this metabolite probably does not play a major role in the PCP effect on QNB binding in rat brain.
Related Publications
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
April 1982,
Life sciences,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
April 1987,
Pharmacology, biochemistry, and behavior,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
January 1999,
Journal of neural transmission (Vienna, Austria : 1996),
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
September 1986,
The Journal of pharmacology and experimental therapeutics,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
January 1995,
Acta physiologica Scandinavica,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
October 1985,
Brain research,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
April 1987,
Biochemical pharmacology,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
July 1989,
European journal of pharmacology,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
January 1994,
Life sciences,
W O Boggan, and
A J Stringer, and
K Faught, and
L D Middaugh
December 1981,
European journal of pharmacology,
